Organon BioSciences Overview

  • Founded
  • 1923
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2
  • Investments
  • 2

Organon BioSciences General Information

Description

Manufacturer of pharmaceutical products. The company develops, manufactures and markets products targeting selected therapeutic areas in human pharmaceuticals and covering a wide range of species in animal health. It offers its products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care and neuroscience, immunology, animal health and oncology.

Contact Information

Website
www.organon.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Molenstraat 110
  • 5342 CC Oss
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Organon BioSciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Organon BioSciences‘s full profile, request access.

Request a free trial

Organon BioSciences Executive Team (1)

Name Title Board Seat Contact Info
Antonius Wilderbeek President & Chief Executive Officer
To view Organon BioSciences’s complete executive team members history, request access »

Organon BioSciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Organon BioSciences‘s full profile, request access.

Request a free trial

Organon BioSciences Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 & 0000000 22-May-2013 000000000 00000 00 Buildings and Property
Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) 26-Jun-2007 Corporate Asset Purchase Buildings and Property 00000000 0000000000
To view Organon BioSciences’s complete investments history, request access »